What Does it Mean to be a Woman in Sports? An Analysis of the Jurisprudence of the Court of Arbitration for Sport
Human Rights Law Review · 13.10.2020 · 20 (3) · 387-411
DOI: 10.1093/hrlr/ngaa020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Rights Law Review, online erschienen am 02.09.2020. Verfasst von Lena Holzer. Die Arbeit wurde bisher 20-mal zitiert (Crossref).
Abstract (Originalsprache)
This article explores the definition of ‘sportswoman’ as put forward in the Caster Semenya case (2019) and the Dutee Chand case (2015) before the Court of Arbitration for Sport (CAS). It analyses the structural and discursive factors that made it possible for the CAS to endorse a definition that reduces sex and gender to a matter concerning testosterone. By relying on the concept of intersectionality and analytical sensibilities from Critical Legal Studies, the article shows that framing the cases as a matter of scientific dispute, instead of as concerning human rights, significantly influenced the CAS decisions. Moreover, structural elements of international sports law, such as the lack of knowledge of human rights among CAS arbitrators and a history of institutionalising gendered and racialised body norms through sporting regulations, further aided the affirmation of the ‘testosterone rules’.
Zitieren
APA
Holzer, L. (2020). What Does it Mean to be a Woman in Sports? An Analysis of the Jurisprudence of the Court of Arbitration for Sport. Human Rights Law Review, 20(3), 387-411. https://doi.org/10.1093/hrlr/ngaa020
Vancouver
Holzer L. What Does it Mean to be a Woman in Sports? An Analysis of the Jurisprudence of the Court of Arbitration for Sport. Human Rights Law Review. 2020;20(3):387-411. doi:10.1093/hrlr/ngaa020
BibTeX
@article{Holzer2020,
author = {Holzer, Lena},
title = {What Does it Mean to be a Woman in Sports? An Analysis of the Jurisprudence of the Court of Arbitration for Sport},
journal = {Human Rights Law Review},
year = {2020},
volume = {20},
number = {3},
pages = {387--411},
doi = {10.1093/hrlr/ngaa020}
}
EUVIMED